Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Cenra Inc.

Market Cap 5.07B 160M 140M 129M 121M 227M 15.12B 229M 1.53B 595M 7.44B 601M 588M 25.84B P/E 2024
15.1x
P/E 2025 14x
Enterprise Value 7.33B 232M 202M 187M 175M 328M 21.84B 330M 2.22B 860M 10.75B 869M 850M 37.33B EV / Sales 2024
0.9x
EV / Sales 2025 0.83x
Free-Float
61.28%
Yield 2024
2.72%
Yield 2025 2.99%
Manager TitleAgeSince
Chief Executive Officer - 05/11/2020
Director of Finance/CFO - 07/03/2014
Chief Administrative Officer - -
Director TitleAgeSince
Director/Board Member - 27/05/2016
Chairman - 05/11/2020
Director/Board Member - 17/01/2020
Change 5-day change 1-year change 3-year change Capi.($)
-0.24%+0.71% - - 160M
+1.34%+3.15%+12.05%+88.11% 46.74B
+0.90%+3.71%+52.88%+91.14% 34.33B
+4.73%+2.49%-5.56%+41.81% 11.57B
+1.37%-0.24%+14.01%+96.33% 11.42B
-0.95%+0.96%+37.43%+127.27% 9.09B
+0.85%-2.39%+15.98%+41.00% 6.98B
-0.98%+1.64%+30.10%+249.20% 6.62B
+4.29%+3.55%+52.31%-15.49% 6.55B
+0.73%-2.94%-35.25%-1.81% 5B
Average +1.20%-0.13%+19.33%+79.73% 15.37B
Weighted average by Cap. +1.35%+0.90%+23.80%+85.41%

Financials

2024 2025
Net sales 8.92B 282M 246M 228M 213M 399M 26.59B 402M 2.7B 1.05B 13.09B 1.06B 1.04B 45.44B 8.57B 271M 236M 219M 205M 384M 25.55B 386M 2.59B 1.01B 12.58B 1.02B 995M 43.66B
Net income 317M 10.03M 8.74M 8.1M 7.58M 14.21M 946M 14.3M 96.05M 37.22M 466M 37.64M 36.83M 1.62B 300M 9.48M 8.27M 7.66M 7.17M 13.44M 895M 13.52M 90.82M 35.2M 440M 35.59M 34.82M 1.53B
Net Debt 2.46B 77.63M 67.69M 62.69M 58.68M 110M 7.32B 111M 744M 288M 3.61B 291M 285M 12.52B 2.26B 71.29M 62.16M 57.57M 53.89M 101M 6.73B 102M 683M 265M 3.31B 268M 262M 11.5B
Logo Cenra Inc.
Cenra Inc is a Taiwan-based company mainly engaged in the provision of general investment related businesses. Through its subsidiary, the Company conducts the development, manufacturing and sales of pharmaceuticals, agricultural and livestock drugs, personal hygiene and health products, as well as the import and sale of medical instruments. Its subsidiaries’ products are pharmaceuticals and health products, including human medicines, such as prescription and indicated drugs, over-the-counter medicines, and disease treatment products; medical equipment, such as blood pressure monitors, blood glucose meters, and artificial joints; animal medicines, supplementary feeds, and feed additives, providing animal treatment, disease prevention, and nutritional supplement products; daily necessities, such as toothpaste, tooth powder, mouthwash and other oral hygiene and health products, hand cleansers, dry hand sanitizers, shower gels, medicated soaps and lotion products, and skin care series.
Employees
-
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!